Skip to main content

Month: August 2020

BeMetals Closes $7.5 Million Brokered Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION ORDISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESVANCOUVER, British Columbia, Aug. 13, 2020 (GLOBE NEWSWIRE) — BeMetals Corp. (TSXV: BMET, OTCQB: BMTLF, Frankfurt: 1OI.F) (the “Company” or “BeMetals”) is pleased to announce that it has closed its previously announced private placement offering by issuing a total of 18.75 million common shares (the “Shares”) at a price of $0.40 per Share (the “Offering Price”) for aggregate gross proceeds of C$7,500,000 (the “Offering”).Haywood Securities Inc. acted as lead agent on behalf of a syndicate of agents that included Canaccord Genuity Corp. and Raymond James Ltd. (the “Agents”).BeMetals President and CEO, John Wilton commented, “We were very pleased by the level...

Continue reading

Crimson Wine Group Announces Webcast Details for Virtual Annual Meeting of Stockholders

NAPA, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) — Crimson Wine Group, Ltd. (OTCQB: CWGL) today announced it will host a live webcast of its 2020 Annual Stockholders’ Meeting on Tuesday, August 25, 2020 at 10 a.m. Pacific Time. This year, in light of the public health impact of the coronavirus (COVID-19) pandemic and the protocols established by federal, state and local governments, the Company is conducting its Annual Meeting exclusively as a virtual meeting via live webcast that can be accessed at https://web.lumiagm.com/228791521. As described in the Company’s proxy statement, filed July 10, 2020, only stockholders of record as of the close of business on June 25, 2020 are entitled to vote at the Annual Meeting.To join the meeting with the ability to vote in the live format, shareholders must enter their 11-digit voter control number...

Continue reading

New data illustrates shifting social media behaviors and expectations among consumers

CHICAGO, Aug. 13, 2020 (GLOBE NEWSWIRE) — Amid the COVID-19 pandemic and a watershed social justice movement, it is no surprise that consumers have increasingly turned to social media. New data from Sprout Social, a leading provider of social media analytics, engagement and advocacy solutions for business, delves deeper into how social media behavior has changed as well as the increased expectations consumers have for brands in this new era.Sprout Social surveyed more than 1,000 U.S. consumers about their use of social media and changes in expectations for brands over the past six months, key findings include:As the pandemic continues, consumers turn to social for the experiences they used to get in person: Over the last six months, 62% of consumers have increased their use of social to connect with friends and family and 48% have...

Continue reading

Proposed Capital Raising by way of a Placing of New Ordinary Shares

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014.NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN AND SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR OTHER MEASURES.THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT. NEITHER THIS ANNOUNCEMENT NOT ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF, OR BE RELIED UPON IN CONNECTION WITH, ANY OFFER OR COMMITMENT WHATSOEVER IN ANY JURISDICTION. ANY DECISION TO PURCHASE, SUBSCRIBE FOR, OTHERWISE ACQUIRE, SELL OR OTHERWISE DISPOSE OF ANY SECURITIES REFERRED TO IN THIS ANNOUNCEMENT MUST BE MADE SOLELY...

Continue reading

Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021

LAVAL, Québec, Aug. 13, 2020 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia (sHTG) (triglyceride blood levels from 500 mg/dL to 1500 mg/dL), today provided a business update and announced its operating and financial results for the first quarter of fiscal 2021 ended June 30, 2020.  Corporate Highlights:Finalized and submitted TRILOGY 2 Statistical Analyses Plan (“SAP”) to the FDA on July 31, 2020Provided business update, on June 29, 2020, in which the Company identified “Triglyceride Normalization” phenomenon prior to patient randomization and treatment as likely contributor to unusually...

Continue reading

Where Food Comes From, Inc. Reports 2020 Second Quarter and Six-Month Financial Results

Second Quarter Highlights – 2020 vs. 2019             Revenue down 10% to $4.4 million from $4.9 million, reflecting impact of COVID-19 restrictions on on-site auditing activity Gross margin increased to 47.6% from 42.7% Net income attributable to WFCF down 3% to $351,000 from $361,000 Adjusted EBITDA down 5% to $782,000 from $824,000Six-Month Highlights – 2020 vs. 2019Revenue down 6% to $8.3 million from $8.8 million Gross margin increased to 44.5% from 42.5% Net income attributable to WFCF down 50% to $110,000 from $218,000 Adjusted EBITDA down 20% to $728,000 from $907,000 Cash generated from operations up 27% to $1.7 million from $1.4 millionCASTLE ROCK, Colo., Aug. 13, 2020 (GLOBE NEWSWIRE) — Where Food Comes From, Inc. (WFCF) (OTCQB: WFCF), the most trusted resource for independent, third-party verification of food production...

Continue reading

Ether Capital Corporation Reports Second Quarter 2020 Financial Results

TORONTO, Aug. 13, 2020 (GLOBE NEWSWIRE) — Ether Capital Corporation (“Ether Capital” or the “Company”) (NEO:ETHC) today reported its financial results as at and for the three months ended June 30, 2020.As at June 30, 2020:The total value of the Ether held by the Company was $9.9 million The total assets of the Company were $13.2 millionThe Company had an accumulated deficit of $32.9 million, the majority of which represents a non-cash unrealized loss on the value of EtherThe Company recorded earnings of $0.15 per common share for the quarter ended June 30, 2020, the majority of which represents a net gain on the fair value remeasurement of Ether.As at August 12, 2020, the total value of the Ether held by the Company was $16.7 million.Brian Mosoff, Ether Capital’s CEO, said: “We are closer than ever to Ethereum’s proof of stake network...

Continue reading

CV Sciences, Inc. Experts Contribute to Journal of Dietary Supplements First Special Issue on Cannabinoids

SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp-derived cannabidiol (CBD) products, is pleased to announce the publication of two papers in the Journal of Dietary Supplements’ first Special Issue on Cannabinoids. In this issue, CV Sciences’ team of physicians and scientists took the opportunity to contribute to the growing body of scientific evidence on hemp-derived CBD as a non-prescription product.Dr. Douglas Mackay, N.D., Senior Vice President of Scientific and Regulatory Affairs for CV Sciences teamed up with Cannabis expert and academic Dr. Igor Koturbash, M.D., Ph.D., Associate Professor and Vice Chair of Environmental and Occupational Health at the Fay W. Boozman College of Public Health, University of Arkansas for...

Continue reading

Cannabix Technologies Provides Update on THC Breath Analyzer Development and Testing

VANCOUVER, British Columbia, Aug. 13, 2020 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that it has been performing user testing with human subjects in Vancouver, BC with its version 2.0 THC Breath Analyzer (“THCBA”). The THCBA device currently provides results in under five minutes. Cannabix has been testing the THCBA device with positive and negative cannabis breath samples with the objective of further training the device’s machine learning database and optimizing components for its upcoming (more robust) version 3.0 device. In recent weeks, Company engineers have also been focusing on device scalability, reducing device production costs, and have tested new thermoplastic...

Continue reading

Open Lending Signs A+ Federal Credit Union to Lenders Protection™ Program

AUSTIN, Texas, Aug. 13, 2020 (GLOBE NEWSWIRE) — Open Lending (NASDAQ: LPRO) provides loan analytics, risk-based pricing, risk modeling and default insurance to auto lenders throughout the United States. They announced today that A+ Federal Credit Union, a $1.9 billion institution based in Austin, TX, has signed with Open Lending to implement their Lenders Protection™ program.“At A+FCU, we strive every day to make a positive financial impact on our members’ lives,” said John Demmler, A+FCU Chief Lending Officer. “Through our new partnership with Open Lending, we can offer our members an alternative to high-interest rate car loans. It’s one more way that we are helping our members and building stronger communities.”Open Lending’s flagship product, Lenders Protection™, is a unique auto lending enablement platform. It utilizes proprietary...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.